Due to health issues, this site is no longer maintained and will be shut down shortly. |
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:IMM.
$1.78 -0.02 (-1.11%)
As of 03/24/2023 15:59:57 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.